PH30476A - Risperidone pamoate - Google Patents
Risperidone pamoateInfo
- Publication number
- PH30476A PH30476A PH48074A PH48074A PH30476A PH 30476 A PH30476 A PH 30476A PH 48074 A PH48074 A PH 48074A PH 48074 A PH48074 A PH 48074A PH 30476 A PH30476 A PH 30476A
- Authority
- PH
- Philippines
- Prior art keywords
- pct
- risperidone
- sec
- compositions
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
- C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93201216 | 1993-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH30476A true PH30476A (en) | 1997-05-28 |
Family
ID=8213799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH48074A PH30476A (en) | 1993-04-28 | 1994-04-08 | Risperidone pamoate |
Country Status (32)
Country | Link |
---|---|
US (2) | US5612346A (sl) |
EP (1) | EP0697019B1 (sl) |
JP (1) | JP3478397B2 (sl) |
KR (1) | KR100307101B1 (sl) |
CN (1) | CN1041727C (sl) |
AT (1) | ATE163418T1 (sl) |
AU (1) | AU675136B2 (sl) |
BG (1) | BG62004B1 (sl) |
CA (1) | CA2160366C (sl) |
CY (1) | CY2107B1 (sl) |
CZ (1) | CZ286688B6 (sl) |
DE (1) | DE69408666T2 (sl) |
DK (1) | DK0697019T3 (sl) |
ES (1) | ES2113652T3 (sl) |
FI (1) | FI109125B (sl) |
GR (1) | GR3026028T3 (sl) |
HK (1) | HK1006059A1 (sl) |
HU (1) | HU218212B (sl) |
IL (1) | IL109448A (sl) |
LV (1) | LV12315B (sl) |
NO (1) | NO305083B1 (sl) |
NZ (1) | NZ266143A (sl) |
PH (1) | PH30476A (sl) |
PL (1) | PL182466B1 (sl) |
RO (1) | RO115955B1 (sl) |
RU (1) | RU2131428C1 (sl) |
SG (1) | SG47046A1 (sl) |
SI (1) | SI9420031B (sl) |
SK (1) | SK280589B6 (sl) |
TW (1) | TW376319B (sl) |
WO (1) | WO1994025460A1 (sl) |
ZA (1) | ZA942909B (sl) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2236700T3 (es) * | 1993-11-19 | 2005-07-16 | Janssen Pharmaceutica N.V. | 1,2-benzazoles microencapsulados. |
US5453425A (en) * | 1994-07-11 | 1995-09-26 | Janssen Pharmaceutica N.V. | Risperidone oral formulation |
TW487572B (en) * | 1996-05-20 | 2002-05-21 | Janssen Pharmaceutica Nv | Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters |
CZ300725B6 (cs) * | 1997-09-30 | 2009-07-29 | Eli Lilly And Company | 2-Methylthienbenzodiazepinová formulace |
US6617321B2 (en) * | 1997-09-30 | 2003-09-09 | Eli Lilly And Company | 2-methyl-thieno-benzodiazepine formulation |
UA72189C2 (uk) * | 1997-11-17 | 2005-02-15 | Янссен Фармацевтика Н.В. | Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот |
BR9914156A (pt) * | 1998-09-30 | 2001-06-26 | Lilly Co Eli | Formulação de 2-metil-tieno-benzodiazepina |
CA2349700A1 (en) * | 1998-11-12 | 2000-05-18 | Merck & Co., Inc. | Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
FR2802101B1 (fr) | 1999-12-10 | 2003-02-28 | Aventis Pharma Sa | Association de cymemazine et d'un neuroleptique atypique |
US6770478B2 (en) * | 2000-02-10 | 2004-08-03 | The Regents Of The University Of California | Erythrocytic cells and method for preserving cells |
US6495164B1 (en) | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
AU2002218494A1 (en) * | 2000-11-29 | 2002-06-11 | Takeda Chemical Industries Ltd. | Medicinal compositions and process for producing the same |
US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
WO2004017975A1 (en) * | 2002-08-23 | 2004-03-04 | Ranbaxy Laboratories Limited | Stable aqueous solutions of risperidone and methods for their preparation |
KR20040034996A (ko) * | 2002-10-18 | 2004-04-29 | 한미약품 주식회사 | 리스페리돈의 개선된 제조방법 |
WO2004094414A1 (en) * | 2003-04-22 | 2004-11-04 | Synthon B.V. | Water soluble salts of risperidone |
US6987111B2 (en) * | 2003-08-06 | 2006-01-17 | Alkermes Controlled Therapeutics, Ii | Aripiprazole, olanzapine and haloperidol pamoate salts |
PL1675573T4 (pl) | 2003-10-23 | 2016-04-29 | Otsuka Pharma Co Ltd | Sterylny preparat do wstrzykiwań arypiprazolu o kontrolowanym uwalnianiu i sposób |
US7884096B2 (en) * | 2003-12-02 | 2011-02-08 | Pharmaneuroboost N.V. | Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
EP2272514A1 (en) * | 2003-12-02 | 2011-01-12 | PharmaNeuroBoost N.V. | Use of low dose pipamperone and a second active compound in the treatment of neurodegenerative diseases |
AU2005209310B2 (en) * | 2004-01-29 | 2011-01-06 | Neuromolecular, Inc. | Combination of a NMDA receptor antagonist and a MAO-inhibitor or a GADPH-inhibitor for the treatment of central nervous system-related conditions |
ATE511512T1 (de) * | 2005-01-05 | 2011-06-15 | Lilly Co Eli | Olanzapinpamoat-dihydrat |
EP1695973A1 (en) * | 2005-02-24 | 2006-08-30 | Neuro3D | Ocaperidone salt and pharmaceutical compositions containing the same |
AR055099A1 (es) * | 2005-07-28 | 2007-08-08 | Alza Corp | Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol |
JP2009508859A (ja) * | 2005-09-15 | 2009-03-05 | エラン ファーマ インターナショナル リミテッド | ナノ粒子アリピプラゾール製剤 |
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
AU2008262545B2 (en) | 2007-05-25 | 2013-12-05 | Indivior Uk Limited | Sustained delivery formulations of risperidone compounds |
ES2661037T3 (es) * | 2007-07-31 | 2018-03-27 | Otsuka Pharmaceutical Co., Ltd. | Procedimientos para producir una suspensión de aripiprazol y una formulación liofilizada |
PT2234617T (pt) * | 2007-12-19 | 2021-05-18 | Janssen Pharmaceutica Nv | Regime de dosagem associado a ésteres de paliperidona injetáveis de longa ação |
ES2972387T3 (es) | 2011-03-18 | 2024-06-12 | Alkermes Pharma Ireland Ltd | Composiciones farmacéuticas que comprenden ésteres de sorbitán |
WO2012147035A1 (en) | 2011-04-26 | 2012-11-01 | Torrent Pharmaceuticals Limited | Acid addition salts of risperidone and pharmaceutical compositions thereof |
EP2827866B1 (en) * | 2012-03-19 | 2023-05-03 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising benzyl alcohol |
JP6219918B2 (ja) | 2012-03-19 | 2017-10-25 | アルカームス ファーマ アイルランド リミテッド | グリセロールエステルを含む医薬組成物 |
NZ630643A (en) | 2012-03-19 | 2017-08-25 | Alkermes Pharma Ireland Ltd | Pharmaceutical compositions comprising fatty acid esters |
EP2833866B1 (en) | 2012-04-04 | 2018-11-21 | Intervet International B.V. | Soft chewable pharmaceutical products |
CN102659577B (zh) * | 2012-04-07 | 2014-07-02 | 安徽绩溪县徽煌化工有限公司 | 一种亚甲基双羟基萘酸的制备方法 |
ES2792149T3 (es) | 2012-09-19 | 2020-11-10 | Alkermes Pharma Ireland Ltd | Composiciones farmacéuticas que tienen estabilidad de almacenamiento mejorada |
US9375433B2 (en) | 2012-09-26 | 2016-06-28 | Tangent Reprofiling Limited | Modulators of androgen synthesis |
NZ706067A (en) | 2012-09-26 | 2016-07-29 | Tangent Reprofiling Ltd | Modulators of androgen synthesis |
AU2015231278B2 (en) | 2014-03-20 | 2020-01-23 | Alkermes Pharma Ireland Limited | Aripiprazole formulations having increased injection speeds |
CN106831594B (zh) * | 2017-01-18 | 2018-02-02 | 力赛生物医药科技(厦门)有限公司 | 可乐定双羟萘酸盐及其制备方法 |
EP3761983A1 (en) | 2018-03-05 | 2021-01-13 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
-
1994
- 1994-03-31 TW TW083102808A patent/TW376319B/zh not_active IP Right Cessation
- 1994-04-08 PH PH48074A patent/PH30476A/en unknown
- 1994-04-22 CZ CZ19952706A patent/CZ286688B6/cs not_active IP Right Cessation
- 1994-04-22 RU RU95119831A patent/RU2131428C1/ru active
- 1994-04-22 PL PL94311282A patent/PL182466B1/pl unknown
- 1994-04-22 ES ES94915538T patent/ES2113652T3/es not_active Expired - Lifetime
- 1994-04-22 SK SK1313-95A patent/SK280589B6/sk not_active IP Right Cessation
- 1994-04-22 DK DK94915538T patent/DK0697019T3/da active
- 1994-04-22 AT AT94915538T patent/ATE163418T1/de active
- 1994-04-22 KR KR1019950704171A patent/KR100307101B1/ko not_active IP Right Cessation
- 1994-04-22 CA CA002160366A patent/CA2160366C/en not_active Expired - Lifetime
- 1994-04-22 JP JP52386294A patent/JP3478397B2/ja not_active Expired - Lifetime
- 1994-04-22 SG SG1996004131A patent/SG47046A1/en unknown
- 1994-04-22 CN CN94191934A patent/CN1041727C/zh not_active Expired - Lifetime
- 1994-04-22 EP EP94915538A patent/EP0697019B1/en not_active Expired - Lifetime
- 1994-04-22 SI SI9420031A patent/SI9420031B/sl unknown
- 1994-04-22 WO PCT/EP1994/001296 patent/WO1994025460A1/en active IP Right Grant
- 1994-04-22 HU HU9501934A patent/HU218212B/hu unknown
- 1994-04-22 US US08/522,422 patent/US5612346A/en not_active Expired - Lifetime
- 1994-04-22 DE DE69408666T patent/DE69408666T2/de not_active Expired - Lifetime
- 1994-04-22 NZ NZ266143A patent/NZ266143A/en not_active IP Right Cessation
- 1994-04-22 RO RO95-01879A patent/RO115955B1/ro unknown
- 1994-04-22 AU AU67216/94A patent/AU675136B2/en not_active Expired
- 1994-04-26 ZA ZA942909A patent/ZA942909B/xx unknown
- 1994-04-27 IL IL109448A patent/IL109448A/xx not_active IP Right Cessation
-
1995
- 1995-10-25 BG BG100094A patent/BG62004B1/bg unknown
- 1995-10-26 NO NO954275A patent/NO305083B1/no not_active IP Right Cessation
- 1995-10-27 FI FI955166A patent/FI109125B/fi not_active IP Right Cessation
-
1996
- 1996-12-24 US US08/773,737 patent/US5723467A/en not_active Expired - Lifetime
-
1998
- 1998-02-26 GR GR980400198T patent/GR3026028T3/el unknown
- 1998-06-11 HK HK98105164A patent/HK1006059A1/xx not_active IP Right Cessation
- 1998-06-16 CY CY9800009A patent/CY2107B1/xx unknown
-
1999
- 1999-02-24 LV LVP-99-32A patent/LV12315B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH30476A (en) | Risperidone pamoate | |
FR05C0045I2 (sl) | ||
HK1002017A1 (en) | Lyospheres comprising gonadotropin | |
HUT72974A (en) | Polypeptide and anti-hiv agent prepared therefrom | |
TW263499B (sl) | ||
PL310171A1 (en) | Novel imidazopyridines | |
ES2104386T3 (es) | Compuesto intermedio para la acitromicina. | |
ZA938414B (en) | Substituted ortho-ethenylphenylacetic acid derivatives | |
TW261516B (sl) | ||
IL107917A0 (en) | Triazoloquinazolines, their preparation and their use as medicaments | |
AU675281B2 (en) | Application of riluzole as a radiorestorer |